Roche targets new central nervous system drugs

January 5, 2007
Research and Development

Swiss-based Roche has forged a partnership that could lead to the development of new treatments for schizophrenia, cognitive disorders, Parkinson's …

GSK buys Praecis Pharmaceuticals for $59 million

January 4, 2007
Research and Development, Sales and Marketing

GlaxoSmithKline has bought US-based biotech company, Praecis, to further boost its novel cancer pipeline.Its acquisition of Praecis Pharmaceuticals follows the …

Diabetic kidney disease drug hits safety obstacle

January 4, 2007
Research and Development, Sales and Marketing

Swiss-based biotech company Speedel has axed its current phase III trial of SPP301 in diabetic kidney disease because of patient …

Positive EU opinion for pancreatic cancer drug Tarceva

January 3, 2007
Sales and Marketing

Roche and Genentech's Tarceva has received a positive EU opinion for the treatment of metastatic pancreatic cancer and approval is …

Hants NHS hospital becomes first to be run by private sector

January 3, 2007

Lymington New Forest Hospital has become the first NHS facility in England to be run entirely by the private sector.Colchester-based …

Are you reaching your customers?

January 3, 2007
Sales and Marketing NHS, healthcare, market access, marketing, strategy

The NHS is changing, and it's doing so at a rate faster than at any time in its history. Huge …

Pharma failing to address MRSA drugs market

January 2, 2007
Research and Development, Sales and Marketing

News that a new strain of the MRSA bug has reached Europe from the US has left drug developers under …

New consultancy to address pharma’s NHS funding challenge

January 2, 2007
Sales and Marketing

A new consultancy has been launched by a team of pharma and NHS veterans to help companies bring new products …

Pfizer launches online pipeline tracker

December 21, 2006
Sales and Marketing

Pfizer has launched a new online service which provides detailed insight into its R&D pipeline.The company is taking a lead …

Government accused of ‘fiddling the books’

December 21, 2006

A leading GP has accused the government of fiddling the books on the uptake of practice-based commissioning.Dr David Jenner, the …

Novartis enters late-stage trials for new hepatitis C drug

December 21, 2006
Research and Development, Sales and Marketing

Novartis, in collaboration with a US biotech company, has initiated phase III trials of a chronic hepatitis C drug that …

KarolSikoraWEB

The Pharmafocus Interview: Karol Sikora, Doctors for Reform

December 20, 2006
Sales and Marketing Doctors for reform, Karol Sikora, NHS

 Karol Sikora, is one of the UK’s leading cancer specialists and a high-profile exponent for radical change in the NHS. …

GSK invests millions in new leukaemia drug

December 20, 2006
Sales and Marketing

UK-based GlaxoSmithKline has pledged a total of £235 million towards developing and selling a new cancer drug.It has teamed up …

NHS must undergo massive change to meet new waiting list target

December 20, 2006

The NHS will have to change radically and rapidly in order to meet a new government target to reduce waiting …

Protherics raises

December 19, 2006
Research and Development

UK-based biotech company Protherics has raised £38 million, which will be split in a three-pronged move to expand its development …

GSK’s mock vaccine gets EU positive opinion

December 19, 2006
Research and Development

GlaxoSmithKline Biological's mock pandemic flu vaccine has received a positive opinion from EU regulators.Daronix is intended to protect against flu …

Are patients about to take charge?

December 18, 2006
Medical Communications, Sales and Marketing NHS, healthcare, information, patients

While debate rages about many aspects of the pharmaceutical industry, one thing is agreed: our world is becoming ever-more patient-centred. …

Confidence in UK medicine safety high

December 15, 2006

After heavy criticism of UK medicines regulator the MHRA last year, a new survey found there is widespread confidence in …

Tycerb in landmark cancer trial

December 15, 2006
Sales and Marketing

GlaxoSmithKline's Tycerb has entered a landmark global trial in the treatment of aggressive breast cancer.This will be the first phase …

Merck outlines turnaround strategy

December 15, 2006
Sales and Marketing

Merck's battle to regain profitability and bring new life to its product pipeline is gathering momentum as its unprecedented reorganisation …

The Gateway to Local Adoption Series

Latest content